Concepedia

Anabel Sanchez‐Spitman

AS

Statistics

Publications

5

Citations

167

H-Index

5

Active since

2017

Affiliations

Leiden University Medical Center(Current)

The Netherlands Cancer Institute

KU Leuven

Reinier de Graaf Hospital

Anabel Sanchez‐Spitman is an author at Leiden University Medical Center specializing in medicine, cancer pharmacogenomics, and cyp2d6 pharmacogenetics.

ORCID

Publications per year

2017–2021

5

Publications

5

Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study

Anabel Sanchez‐Spitman, Vincent O. Dezentjé, Jesse J. Swen et al. · Journal of Clinical Oncology · 2019 · 90 citations · Full text

, , +14

Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy

Anabel Sanchez‐Spitman, Vincent O. Dezentjé, Jesse J. Swen et al. · Breast Cancer Research and Treatment · 2018 · 25 citations · Full text

, , +17

The Effect of rs5758550 on <i>CYP2D6*2</i> Phenotype and Formation of Endoxifen in Breast Cancer Patients Using Tamoxifen

Anabel Sanchez‐Spitman, Dirk-Jan A. R. Moes, Hans Gelderblom et al. · Pharmacogenomics · 2017 · 22 citations

, , +17

Exposure–response analysis of endoxifen serum concentrations in early-breast cancer

Anabel Sanchez‐Spitman, Dirk-Jan A. R. Moes, Jesse J. Swen et al. · Cancer Chemotherapy and Pharmacology · 2020 · 15 citations · Full text

, , +16

Effect of CYP2C19 genotypes on tamoxifen metabolism and early-breast cancer relapse

Anabel Sanchez‐Spitman, Jesse J. Swen, Vincent O. Dezentjé et al. · Scientific Reports · 2021 · 15 citations · Full text

, , +16

1–5 of 5